Series Ventures Makes Seed Investment in Visual Terminalology

Series Ventures (CEO Park Jun-sang and Kwak Seong-wook) announced that it has completed seed investment in Visual Terminalology (CEO Choi Byeong-gwan), a healthcare startup developing a digital twin-based AI health/medical avatar platform.

With the investment secured this time, Visual Terminalology plans to enhance its AI health/medical avatar platform, which is currently under development, and complete the construction of a smart hospital system in collaboration with Pusan National University Hospital and others. It also plans to launch API partnerships and its own mobile app, 'DaOn', in earnest.

Through the AI health/medical avatar service, numerous diseases and health information that are difficult for the general public to understand are easily visualized and displayed at a glance through the user's avatar, allowing patients to more efficiently understand their health status and disease information. Furthermore, through its own AI technology, it provides services such as health improvement plans and implementation monitoring to all users to help them maintain a healthy life.

Furthermore, we plan to enable more users to utilize our health/medical avatar services through API partnerships with insurance companies and fintech companies entering the healthcare sector, and we plan to expand our services to medical institutions and health screening centers that require visualized avatar solutions.

Series Ventures CEOs Park Jun-sang and Kwak Seong-wook explained the investment background, saying, “Visual Terminalology is a team with differentiated technology and execution capabilities in the AI-based healthcare market,” and “We expect high growth in the smart hospital construction and healthcare platform markets in the future.”

Visual Terminalology CEO Choi Byeong-gwan added, “With this investment, we will accelerate sales growth by promoting full-scale entry into the B2C and B2B markets for our health/medical avatar solutions, and through this, we will strive to achieve follow-up investments and rapid company growth, benefiting both investors and company members.”


  • See more related articles